| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/15/2012 | CN101804051B Liposome injection of pharmaceutical composition of amoxicillin sodium and clavulanate potassium |
| 02/15/2012 | CN101785865B pH响应型两亲接枝聚膦腈给药胶束及其制备方法 pH-responsive amphiphilic graft polyphosphazene micelles and preparation method of administration |
| 02/15/2012 | CN101721711B 邻菲咯啉钌环糊精-金刚烷芘-单壁碳纳米管三元超分子体系的制备方法及应用 Phenanthroline ruthenium cyclodextrin - adamantane pyrene - single-walled carbon nanotube preparation and application of ternary supramolecular system |
| 02/15/2012 | CN101716348B 一种基于金磁纳米粒子的载药平台的构建与应用 Construction and Application of gold based on magnetic nanoparticles drug loading platform |
| 02/15/2012 | CN101678121B 对肿瘤细胞具有杀伤作用的改性羟基聚合物共轭物 Hydroxyl polymer-modified tumor cell killing effect of having a conjugate |
| 02/15/2012 | CN101637607B 一种龙虎人丹植物药组合物及其制备和应用 One kind of dragon Dan botanical composition and preparation and application |
| 02/15/2012 | CN101636414B 聚乙二醇修饰的干扰素α2b及其制备方法和应用 Pegylated interferon α2b and its preparation method and application |
| 02/15/2012 | CN101633699B 一种含抗体模拟物的新型抗生素及其制备方法与应用 New antibiotics and its preparation method and application containing antibody mimetics |
| 02/15/2012 | CN101516402B 凝胶状经肠营养剂 Gel-type enteral nutrient |
| 02/15/2012 | CN101475503B 一种新型阳离子类脂及其制备方法和应用 A novel cationic lipid and its preparation method and application |
| 02/15/2012 | CN101468014B 喷昔洛韦乳膏的制备工艺 Penciclovir cream preparation Lowe |
| 02/15/2012 | CN101172099B 稳定等渗的冻干蛋白质制剂 Stable lyophilized protein formulations isotonic |
| 02/14/2012 | US8114981 Method and medicament for inhibiting the expression of a given gene |
| 02/14/2012 | US8114965 Compositions of PSMA antibodies |
| 02/14/2012 | US8114855 Low density cosmetic formulations, cosmetic products containing the same and methods of treating hair, nails and/or skin using the same |
| 02/14/2012 | US8114851 Double stranded RNA packaged in liposome for use therapeutic tool in treatment of cell proliferative and viral disorders; Antisense oligonucleotide for use in prevention and treatment of viral and tumor disorders; gene expression inhibition; RNA interference |
| 02/14/2012 | US8114833 Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices |
| 02/14/2012 | US8114831 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 02/14/2012 | US8114455 Process for manufacturing chewable dosage forms for drug delivery and products thereof |
| 02/14/2012 | US8114442 Transdermal pharmaceutical delivery compositions |
| 02/14/2012 | US8114438 DPI formulation containing sulfoalkyl ether cyclodextrin |
| 02/14/2012 | US8114434 Diclofenac sodium patches for topical treatment of pain |
| 02/14/2012 | US8114421 Coated products containing hydrogenated indigestible starch syrup as a binding agent |
| 02/14/2012 | US8114418 Chimeric immunomodulatory compounds and methods of using the same—IV |
| 02/14/2012 | US8114328 Method of coating a dosage form comprising a first medicant |
| 02/14/2012 | CA2549730C Chemically modified small molecules |
| 02/14/2012 | CA2516291C Dosage form having a saccharide matrix |
| 02/14/2012 | CA2402160C Heparinase iii and uses thereof |
| 02/14/2012 | CA2364606C Oil-in-water emulsion for the use as medicament or for producing a medicament |
| 02/09/2012 | WO2012019047A2 Subconjunctival implant for posterior segment drug delivery |
| 02/09/2012 | WO2012019024A2 Her3-binding molecules and immunoconjugates thereof |
| 02/09/2012 | WO2012018715A1 Collagen-based implants for sustained delivery of drugs |
| 02/09/2012 | WO2012018383A2 Interior functionalized hyperbranched dendron-conjugated nanoparticles and uses thereof |
| 02/09/2012 | WO2012018380A2 Compositions and methods for inducing immune tolerance |
| 02/09/2012 | WO2012018377A2 Liposome targeting compounds and related uses |
| 02/09/2012 | WO2012018306A1 A multicompartmentalized vesicular structure and a method for forming the same |
| 02/09/2012 | WO2012018240A2 Preparation of extremely small and uniform sized, iron oxide-based paramagnetic or pseudo-paramagnetic nanoparticles and mri t1 contrast agents using the same |
| 02/09/2012 | WO2012018115A1 Composition for regeneratng normal tissue from fibrotic tissue |
| 02/09/2012 | WO2012018069A1 Preparation for treatment of spinal cord injury |
| 02/09/2012 | WO2012018068A1 Pharmaceutical preparation for controlling water-soluble drug release |
| 02/09/2012 | WO2012018056A1 Compressed composition |
| 02/09/2012 | WO2012017892A1 Transdermal patch and method for augmenting adhesive strength thereof |
| 02/09/2012 | WO2012017408A1 Preparation of conjugates comprising adenine derivatives and allergenic proteins and their use for specific immunotherapy of allergenic diseases |
| 02/09/2012 | WO2012017406A1 Exogenous pulmonary surfactant preparation comprising a phospholipid and an adjuvans |
| 02/09/2012 | WO2012017383A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating biopolymer, beclomethasone dipropionate, terbinafine hydrochloride and a process to make it |
| 02/09/2012 | WO2012017382A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating biopolymer, beclomethasone dipropionate, miconazole nitrate and a process make it |
| 02/09/2012 | WO2012017381A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating, biopolymer, beclomethasone dipropionate, clotrimazole and a process to make it |
| 02/09/2012 | WO2012017371A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, clobetasole propionate, terbinafine hydrochloride and a process to make it |
| 02/09/2012 | WO2012017370A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, betamethasone dipropionate, terbinafine hydrochloride and a process to make it |
| 02/09/2012 | WO2012017369A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating biopolymer, betamethasone dipropionate, clotrimazole and a process to make it |
| 02/09/2012 | WO2012017368A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, beclomethasone dipropionate and a process to make it |
| 02/09/2012 | WO2012017349A2 An improved topical pharmaceutical composition comprising nanonized silver sulfadiazine |
| 02/09/2012 | WO2012017290A1 Inclusion complexes of cyclodextrins with spermidine, and proliferative/reparative compositions comprising thereof |
| 02/09/2012 | WO2012017156A1 Concentrated human immunoglobulin composition |
| 02/09/2012 | WO2012017119A2 Non-viral vectors for gene therapy |
| 02/09/2012 | WO2012017022A2 Pharmaceutical composition containing a serenoa repens extract |
| 02/09/2012 | WO2012017003A1 Anti-mhc antibody anti-viral cytokine fusion protein |
| 02/09/2012 | WO2012016918A1 Use of a peptide enhancing the ability of radiation therapy to kill cancer cells |
| 02/09/2012 | WO2012016703A2 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine |
| 02/09/2012 | WO2012016698A2 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for the treatment of neuropathic pain |
| 02/09/2012 | WO2012016697A2 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for the treatment of nociceptive pain |
| 02/09/2012 | US20120035296 Bone cement composition, bone cement composition kit and forming method of bone cement hardened material |
| 02/09/2012 | US20120035278 Preparing aminotriazine alkoxylates |
| 02/09/2012 | US20120035277 Liquid-filled chewable supplement |
| 02/09/2012 | US20120035276 Tissue regenerative composition, method of making, and method of use thereof |
| 02/09/2012 | US20120035205 Treatment for basal cell carcinoma |
| 02/09/2012 | US20120035146 Implants and methods for treating inflammation-mediated conditions of the eye |
| 02/09/2012 | US20120035128 Polysaccharide derivative and hydrogel thereof |
| 02/09/2012 | US20120035107 Compositions for achieving a therapeutic effect in an anatomical structure |
| 02/09/2012 | US20120034656 Neutralising Antibody Molecules Having Specificity for Human IL-17 |
| 02/09/2012 | US20120034304 Prolonged Release Pharmaceutical Composition Containing 3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)Phenol |
| 02/09/2012 | US20120034298 Chewable Soft Capsule |
| 02/09/2012 | US20120034292 Composition For Transdermal Delivery Of Fentanyl |
| 02/09/2012 | US20120034259 Antigen delivery vectors and constructs |
| 02/09/2012 | US20120034247 Monomethylvaline compounds capable of conjugation to ligands |
| 02/09/2012 | US20120034246 Monomethylvaline compounds capable of conjugation to ligands |
| 02/09/2012 | CA2807528A1 St-246 liquid formulations and methods |
| 02/09/2012 | CA2807376A1 Collagen-based implants for sustained delivery of drugs |
| 02/09/2012 | CA2807314A1 Film-forming composition for soft capsules |
| 02/09/2012 | CA2807274A1 Interior functionalized hyperbranched dendron-conjugated nanoparticles and uses thereof |
| 02/09/2012 | CA2807225A1 Pharmaceutical preparation for controlling water-soluble drug release |
| 02/09/2012 | CA2807224A1 Preparation for treatment of spinal cord injury |
| 02/09/2012 | CA2807150A1 Corticosteroids for the treatment of joint pain |
| 02/09/2012 | CA2807141A1 Compositions and methods for inducing immune tolerance |
| 02/09/2012 | CA2807139A1 Liposome targeting compounds and related uses |
| 02/09/2012 | CA2805685A1 Concentrated human immunoglobulin composition |
| 02/09/2012 | CA2805564A1 Anti-mhc antibody anti-viral cytokine fusion protein |
| 02/09/2012 | CA2805525A1 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for the treatment of neuropathic pain |
| 02/09/2012 | CA2805523A1 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for the treatment of nociceptive pain |
| 02/09/2012 | CA2797101A1 Preparation of extremely small and uniform sized, iron oxide-based paramagnetic or pseudo-paramagnetic nanoparticles and mri t1 contrast agents using the same |
| 02/08/2012 | EP2415871A1 Polyion complex of double-stranded ribonucleic acid |
| 02/08/2012 | EP2415800A1 Hyperbranched polyoxyalkylene compound and method for producing same |
| 02/08/2012 | EP2415775A1 Agent for inhibiting thickening of peritoneal membrane |
| 02/08/2012 | EP2415487A1 An ultrasonic couplant composition and methods for producing |
| 02/08/2012 | EP2415486A2 Conjugates and compositions for cellular delivery |
| 02/08/2012 | EP2415485A1 Hard capsule |
| 02/08/2012 | EP2415484A1 Sustained local anesthetic composition containing SAIB |
| 02/08/2012 | EP2415477A1 Traditional chinese medicinal ointment for treating burn, scald and infective trauma and preparative method thereof |
| 02/08/2012 | EP2415472A1 Solid pharmaceutical composition containing amorphous body of solifenacin |
| 02/08/2012 | EP2415470A1 Liposome composition |